What You Should Know:
- Cleveland Clinic and Dyania Health have announced a collaboration to integrate Dyania's Synapsis™ AI platform across Cleveland Clinic’s clinical research enterprise.
- The partnership, which follows successful pilot programs in cardiology, oncology, and neurology, aims to accelerate clinical trial recruitment by using medically trained large language models (LLMs) to speed up and scale patient identification for research studies. The ultimate goal is to provide more
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization
What You Should Know:
- EVERSANA and Waltz Health have announced a merger valued at $6B to form a unified healthcare platform that will redefine pharmaceutical commercialization and patient access.
- The merger combines Waltz Health’s software-powered drug-price marketplaces and direct-to-payer model with EVERSANA’s global commercialization services. The new organization aims to deliver a next-generation approach to drug access and value in the U.S. healthcare system, particularly
Read More
M&A: Advent International to Acquire PatientPoint in Strategic Deal
What You Should Know:
- Advent International, a global private equity investor, has signed a definitive agreement to acquire PatientPoint, a digital point-of-care network.
- The acquisition, from an investor group led by L Catterton and Littlejohn & Co., is expected to close in the fourth quarter of 2025, pending regulatory approvals. Financial terms of the transaction were not disclosed.
PatientPoint Overview
PatientPoint has over 35 years of experience transforming the
Read More
Sleep.ai Raises $5.5M to Lead AI-Powered Sleep Intelligence Market
What You Should Know:
- Sleep.ai, formerly known as SleepScore Labs secures $5.5M in venture funding led by Treasure Coast Ventures, with participation from Nurture Ventures, the Harvard Business School Alumni Angels of Greater New York, Supermoon Capital, and several other investors.
- The funding will help Sleep.ai accelerate commercialization, expand its partner integrations, and extend its reach across health, wellness, insurance, and other sectors.
Sleep.ai Inception
Read More
Carna Health & Siemens Healthineers Partner to Advance AI-Powered CKD Screening
What You Should Know:
- Carna Health, a digital health company focused on kidney care, has announced a strategic agreement with Siemens Healthineers. The collaboration aims to accelerate the adoption of Carna's AI-enabled chronic kidney disease (CKD) platform and bring point-of-care testing systems to emerging markets.
- This will help improve early detection and CKD management for high-risk and underserved populations by integrating Carna Health’s digital platforms with Siemens
Read More
American Heart Association Launches Virtual Care Program to Reduce Heart Failure Readmissions
What You Should Know:
- With chronic disease rates rising and nearly one in four heart failure patients readmitted to the hospital within 30 days of discharge, healthcare systems face ongoing challenges in reducing hospital stays and readmissions. To address this critical gap, the American Heart Association has launched American Heart Association Connected Care™, Powered by Cadence. This new virtual care program delivers ongoing heart and cardiometabolic care to patients at home after their
Read More
Nomi Health Report Reveals the “MSK Paradox”: Why Office Workers Have Higher Injury Rates
What You Should Know:
- New data from Nomi Health reveals a counterintuitive trend dubbed the "MSK Paradox": white-collar employees report significantly higher rates of musculoskeletal (MSK) disorders than their blue-collar counterparts.
- A national analysis of 435 employers showed that employees in office-based, professional roles had 38% higher MSK rates than skilled laborers. The study found that 27% of office workers reported incidents of back pain, compared to just 18% of
Read More
AbbVie Acquires Gilgamesh’s Psychedelic MDD Program For Up To $1.2B
What You Should Know:
- AbbVie and Gilgamesh Pharmaceuticals Inc. have announced a definitive agreement for AbbVie to acquire Gilgamesh's lead investigational candidate, bretisilocin, which is in clinical development for the treatment of patients with moderate-to-severe major depressive disorder (MDD).
- The deal is valued at up to $1.2B, which includes an upfront payment and development milestones. As part of the acquisition, Gilgamesh will spin off a new entity that will
Read More
Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights
What You Should Know:
- Mira, a hormonal health company, has launched Ultra4™, the first at-home hormone monitor to provide lab-quality insights.
- The new device tracks four key hormones—FSH, LH, E3G, and PdG—with a single wand and a 16-minute test. For the first time, people can monitor their entire cycle from home, from ovulation strength to hormonal balance, with the same precision previously available only in clinics.
Why Tracking Four Hormones Matters
Ultra4™'s technology
Read More
Sonio Launches New AI-Powered Product Suite to Enhance Maternal Healthcare in the U.S.
What You Should Know:
- Sonio, a MedTech company specializing in women’s and children’s health, has announced a new range of product offerings designed to serve the maternal community across the U.S..
- The new product offerings, which include Sonio Start, Sonio Plus, Sonio Premium, and Sonio Enterprise, are designed to meet the different needs of clinics and health systems at every level of care.
Addressing Inefficiencies with AI and Automation
The new offerings were specifically
Read More
